欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > MAPK > PLX-4720

浏览历史

S81102

PLX-4720

源叶(MedMol) 99%
  • 英文名:
  • PLX-4720
  • 别名:
  • N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
  • CAS号:
  • 918505-84-7
  • 分子式:
  • C17H14ClF2N3O3S
  • 分子量:
  • 413.83
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81102-5mg 99% ¥255.00元 8 - - - EA 加入购物车
源叶(MedMol) S81102-10mg 99% ¥425.00元 6 - - - EA 加入购物车
源叶(MedMol) S81102-25mg 99% ¥680.00元 8 - - - EA 加入购物车
源叶(MedMol) S81102-50mg 99% ¥935.00元 8 - - - EA 加入购物车
源叶(MedMol) S81102-100mg 99% ¥1700.00元 6 - - - EA 加入购物车
源叶(MedMol) S81102-200mg 99% ¥2975.00元 5 - - - EA 加入购物车
源叶(MedMol) S81102-500mg 99% ¥4930.00元 5 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: PLX-4720 is a potent and selective inhibitor of B-RafV600E with IC50 of 13 nM in a cell-free assay, equally potent to c-Raf-1(Y340D and Y341D mutations), and 10-fold selectivity for B-RafV600E than wild-type B-Raf.
  • 靶点: B-RafV600E:13 nM (IC50);B-Raf:160 nM (IC50);BRK:130 nM (IC50);FRK:1300 nM (IC50);Csk:1500 nM (IC50);Src:1700 nM (IC50);FAK:1700 nM (IC50);FGFR:1900 nM (IC50);KDR:2300 nM (IC50);HGK:2800 nM (IC50);CSF1R:3300 nM (IC50);Aurora A:3400 nM (IC50);Raf
  • 体内研究:
    Oral administration of PLX-4720 at 20 mg/kg/day induces significant tumor growth delays and regressions in B-RafV600E-dependent COLO205 tumor xenografts, without obvious adverse effects in mice even at dose of 1 g/kg. PLX-4720 at 100 mg/kg twice daily almost completely eliminates the 1205Lu xenografts bearing B-RafV600E, while has no activity against C8161 xenografts bearing wild-type B-Raf. The anti-tumor effects of PLX-4720 correlate with the blockade of MAPK pathway in those cells harboring the V600E mutation. PLX-4720 treatment at 30 mg/kg/day significant inhibits the tumor growth of 8505c xenografts by >90%, and dramatically decreases distant lung metastases
  • 参考文献:
    1. Tsai J, et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci U S A, 2008, 105(8), 3041-3046. 2. Paraiso KH, et al. PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res, 2011, 71(7), 2750-2760. 3. Nucera C, et al. B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A, 2010, 107(23), 10649-10654. 4. Rizzolio S, et al. Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies. J Clin Invest. 2018 Aug 31;128(9):3976-3990.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.416 ml 12.082 ml 24.165 ml
    5 mM 0.483 ml 2.416 ml 4.833 ml
    10 mM 0.242 ml 1.208 ml 2.416 ml
    50 mM 0.048 ml 0.242 ml 0.483 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。